ACERUS BIOPHARMA INC. logo

ACERUS BIOPHARMA INC.

9 Marks
Corp.
First Filed:Oct 7, 2013Latest Filed:Sep 15, 2022Address:7025 Langer Drive, Suite 205, Mississauga, Ontario, L5N0E8, CA

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
8(89%)
Class 10
Medical Apparatus
2(22%)
Class 16
Paper Goods and Printed Matter
1(11%)

TTAB Proceedings

No litigation activity

Top Firms

Loading...

Trademark Portfolio

9 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
TRIVAIR DEPOSITION SYSTEM
TRIVAIR DEPOSITION SYSTEM
Trademark
Combined
ABANDONED
Owner:
Serial:97593472
Filed:Sep 15, 2022
Classes:5, 10
Goods & Services
Inhalers filled with pharmaceutical preparations for use in the treatment of respiratory diseases; "AIR" AND "DEPOSITION SYSTEM"; Medical apparatus and instruments, namely, inhalers, sold empty, for therapeutic use in the administering of pharmaceutical preparations
TESTOSTEROWN
TESTOSTEROWN
Trademark
Word
REGISTERED
Owner:
Serial:90095710
Filed:Aug 5, 2020
Classes:16, 44
Registration:6357861
Registered:May 18, 2021
Goods & Services
Class 016: Printed matter, namely, pamphlets, brochures, newsletters, manuals, booklets, leaflets, charts, catalogues, paper displays and posters relating to pharmaceutical treatment and management of diseases or conditions related to testosterone deficiency; Class 044: Medical information services, namely, providing information relating to pharmaceutical treatment and management of diseases or conditions related to testosterone deficiency; providing information relating to pharmaceutical treatment and management of diseases or conditions related to testosterone deficiency via a website
NATESTO N
NATESTO N
Trademark
Combined
REGISTERED
Owner:
Serial:90002018
Filed:Jun 15, 2020
Classes:5
Registration:6350052
Registered:May 11, 2021
Goods & Services
Pharmaceutical preparations, namely, testosterone supplementation
TRIVAIR
TRIVAIR
Trademark
Word
ABANDONED
Owner:
Serial:88830833
Filed:Mar 11, 2020
Classes:5, 10
Goods & Services
Inhalers filled with pharmaceutical preparations for use in the treatment of respiratory diseases, disorders and infections; inhalers filled with pharmaceutical preparations for use in the treatment of asthma; inhalers filled with pharmaceutical preparations for use in the treatment of chronic obstructive pulmonary disease; inhalers filled with pharmaceutical preparations for use in the treatment of rhinitis; inhalers filled with pharmaceutical preparations for use in the treatment of sinus polyps; inhalers filled with pharmaceutical preparations for use in the treatment of viral airway infections; inhalers filled with pharmaceutical preparations for use in the treatment of multiple sclerosis; inhalers filled with pharmaceutical preparations for use in the treatment of depression; inhalers filled with pharmaceutical preparations for use in the treatment of epilepsy; inhalers filled with pharmaceutical preparations for use in the treatment of migraine; inhalers filled with pharmaceutical preparations for use in the treatment of Alzheimer's disease; inhalers filled with pharmaceutical preparations for use in the treatment of Parkinson's disease; inhalers filled with pharmaceutical preparations for use in the treatment of cerebrovascular accident or stroke; inhalers filled with pharmaceutical preparations for use in the treatment of traumatic brain injury; inhalers filled with pharmaceutical preparations for use in the treatment of cancer; inhalers filled with pharmaceutical preparations for use in the treatment of nausea; inhalers filled with pharmaceutical preparations for use in the treatment of post-traumatic stress disorder; inhalers filled with pharmaceutical preparations for use in the treatment of amyotrophic lateral sclerosis; inhalers filled with pharmaceutical preparations for use in the treatment of chronic pain; inhalers filled with pharmaceutical preparations for use in the treatment of insomnia; inhalers filled with pharmaceutical preparations for use in the relief of pain; inhalers filled with pharmaceutical preparations for use in the treatment of cough or sore throat; inhalers filled with pharmaceutical preparations for use in the treatment of candida infection; inhalers filled with pharmaceutical preparations for use in anti-fungal treatment; inhalers filled with pharmaceutical preparations for use in sedation; inhalers filled with pharmaceutical preparations for use in hormone replacement therapy; inhalers filled with pharmaceutical preparations for use in the treatment of psychosis; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of respiratory diseases, disorders and infections; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of asthma; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of chronic obstructive pulmonary disease; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of rhinitis; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of sinus polyps; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of viral airway infections; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of multiple sclerosis; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of depression; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of epilepsy; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of migraine; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of Alzheimer's disease; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of Parkinson's disease; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of cerebrovascular accident or stroke; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of traumatic brain injury; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of cancer; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of nausea; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of post-traumatic stress disorder; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of amyotrophic lateral sclerosis; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of chronic pain; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of insomnia; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the relief of pain; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of cough or sore throat; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of candida infection; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in anti-fungal treatment; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in sedation; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in hormone replacement therapy; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of psychosis; inhalers used to deliver therapeutic agents, namely, analgesics, sedatives, vaccines, anesthetics, insulin, antiemetics, antifungals, hormones, or antipsychotics; drug delivery devices, namely, breath actuated nasal delivery devices used to deliver therapeutic agents, namely, analgesics, sedatives, vaccines, anesthetics, insulin, antiemetics, antifungals, hormones, or antipsychotics; inhalers filled with analgesics, sedatives, vaccines, anesthetics, insulin, antiemetics, antifungals, hormones, respiratory therapeutic agents, or antipsychotics; drug delivery devices, namely, breath actuated nasal delivery devices filled with analgesics, sedatives, vaccines, anesthetics, insulin, antiemetics, antifungals, hormones, respiratory therapeutic agents, or antipsychotics; none of the foregoing containing cannabis or CBD; Medical apparatus and instruments, namely, inhalers, sold empty, for therapeutic use; medical apparatus and instruments, namely, breath actuated nasal drug delivery devices, sold empty, for therapeutic use; none of the foregoing for use with cannabis or CBD
TEFINA
TEFINA
Trademark
Word
ABANDONED
Owner:
Serial:88350154
Filed:Mar 21, 2019
Classes:5
TRI AIR DEPOSITION SYSTEM
TRI AIR DEPOSITION SYSTEM
Trademark
Combined
ABANDONED
Owner:
Serial:88117654
Filed:Sep 14, 2018
Classes:5
Goods & Services
"AIR" AND "DEPOSITION SYSTEM"
TEFINA
TEFINA
Trademark
Word
ABANDONED
Owner:
Serial:86743050
Filed:Aug 31, 2015
Classes:5
TRI AIR DEPOSITION SYSTEM
TRI AIR DEPOSITION SYSTEM
Trademark
Combined
ABANDONED
Owner:
Serial:86497842
Filed:Jan 7, 2015
Classes:5
Goods & Services
"AIR", "DEPOSITION", OR "SYSTEM"
NATESTO
NATESTO
Trademark
Word
REGISTERED
Owner:
Serial:86084664
Filed:Oct 7, 2013
Classes:5
Registration:4761006
Registered:Jun 23, 2015
Goods & Services
Pharmaceutical preparations, namely, testosterone supplementation